Healthcare Entrepreneur Fred Eshelman, Pharm.D., Appointed Board Chairman Aravive’s Chief Scientific Officer, Gail McIntyre, Ph.D., Appointed CEO Aravive to Host Conference Call Today at 9:00 AM ET HOUSTON, April 09, 2020 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, today announced transitions in its board of directors
InGeneron announces publication of favorable results using regenerative cells isolated from patients’ own body fat prepared with the Transpose® RT System in the Journal of Orthopaedic Surgery and Research. Houston, TX, April 7, 2020 – Results of a U.S. FDA-approved, randomized controlled feasibility study on treatment of symptomatic partial-thickness rotator
Plasmid CDMO VGXI, Inc. Completes Manufacturing and Release of a Vaccine against COVID-19 in Record-Setting Time April 6, 2020; The Woodlands, TX – VGXI, an industry leading provider of GMP grade plasmid DNA for vaccines and gene therapies, announced it has completed manufacturing and release of a DNA vaccine to
March 11, 2020 – Houston, Texas – As a precaution resulting from the COVID-19 outbreak, we have decided that it would be prudent to reschedule this year’s 17th Annual Chili Cookoff. The new date for the event will be Friday, October 2, 2020. The time and location will remain unchanged
Brian Toglia, president and CEO of Galiot Insurance Services in Houston, has merged operations with Higginbotham. Brian, who …
Goal to Enroll Up to 60 Patients in Twelve Month Study Accrual Period